logo

Akebia Therapeutics, Inc. (AKBA)



Trade AKBA now with
  Date
  Headline
1/4/2018 7:05:11 AM Akebia Therapeutics Announces Positive Top-Line Results From Phase 2 Study Of Vadadustat
11/7/2014 9:36:09 AM Nomura Reiterates Akebia Therapeutics, Inc. (AKBA) At Buy With $39 Price Target
4/14/2014 10:51:24 AM Nomura Initiates Akebia Therapeutics, Inc. (AKBA) At Buy With $39 Price Target
  
 
>